Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Precision Oncology: Genomics Guided Care - Taxonomy and Framework for Development of Tumour-Agnostic Precision Therapeutics 2024

Aired live on 17 Apr 2024

ESMO-Webinar-series-Taxonomy-Tumour-Agnostic-Therapeutics-1000x250

Precision Oncology: Genomics Guided Care - Taxonomy and Framework for Development of Tumour-Agnostic Precision Therapeutics 2024

Chair: Benedikt Westphalen
Co-Chair: George Pentheroudakis
Speakers: Claudia Cardone, Vivek Subbiah, Sewanti Limaye

ESMO-Webinar-series-Taxonomy-Tumour-Agnostic-Therapeutics-1000x250

Login to get immediate access to this content.

Login

Learning objectives:

  • To discuss a proposal for a taxonomy of tissue agnostic therapeutics.
  • To highlight the scientific issues and clinical trial designs pertaining to the development of oncology drugs agnostic of tumour type.
  • To explore the opportunities and challenges in development of a framework for drug development in a tumour agnostic manner.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.